Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

NCT02627807 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

386

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

RADIATION: IMRT using individualized CTV
RADIATION: IMRT using traditional CTV
DRUG: Gemcitabine and cisplatin (induction chemotherapy)
DRUG: Docetaxel and cisplatin (induction chemotherapy)
DRUG: Cisplatin 100mg/m² concurrent chemotherapy
DRUG: Cisplatin 80mg/m² concurrent chemotherapy

Sponsor

Sun Yat-sen University